Bodal Chemicals to hold 39th AGM on 26 September 2025, to consider key re-appointments and auditor changes
The announcement details several key governance decisions including the re-appointment of top management and independent directors, along with changes in statutory auditors due to a merger. These are important decisions for corporate structure and continuity, warranting a medium impact, though they are largely expected as part of an AGM agenda.
The announcement outlines routine corporate governance matters such as the Annual General Meeting, re-appointment of directors, and auditor changes. These are standard procedures and do not inherently indicate a positive or negative outlook for the company.
* Bodal Chemicals Limited announced that its 39th Annual General Meeting (AGM) will be held on Friday, 26th September 2025, at 12:00 Noon IST through Video Conference (VC)/Other Audio Visual Means (OAVM). * The AGM will consider and adopt the Audited Standalone and Consolidated Financial Statements for the financial year ended 31st March 2025. * Shareholders will vote on the re-appointment of Mr. Rajarshi Gosh as a Director, who retires by rotation. * The company proposes to approve the appointment of M/s. B N P S and Associates LLP as Statutory Auditor for the period from FY2022-23 to FY2026-27, consequent upon the merger of M/s. Naresh J. Patel & Co. * Remuneration of `1,65,000 (Rupees One lakh sixty five thousand only)` plus GST for M/s. Kiran J. Mehta & Co., Cost Auditors for FY2025-26, will be ratified. * M/s Shah & Shah Associates, Company Secretaries, are proposed to be appointed as Secretarial Auditor for five consecutive years from FY2025-26 to FY2029-30. * Mr. Mayank K. Mehta is proposed for re-appointment as an Independent Director for a second term of five years, from 08th February 2026 to 08th February 2031. * Mr. Suresh J. Patel is proposed for re-appointment as Chairman and Managing Director for a period of three years, effective 13th May 2026, with a basic salary of `9,00,000/- per month` (scale up to `18,00,000` with annual increment of up to 20%) and a commission of up to 3% of net profit. * Mr. Bhavin S. Patel is proposed for re-appointment as Executive Director for a period of three years, effective 13th May 2026, with a basic salary of `6,00,000/- per month` (scale up to `16,00,000` with annual increment of up to 20%) and a commission of up to 2% of net profit. * No dividend has been recommended by the Board of Directors at this AGM. * The Register of Members and Share Transfer Book will remain closed from Saturday, 20th September 2025 to Friday, 26th September 2025. * The cut-off date for e-voting eligibility is Friday, 19th September 2025, with the e-voting period running from Tuesday, 23rd September 2025, to Thursday, 25th September 2025.
What to do with a filing like this
Bodal Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under corporate actions. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Bodal Chemicals Limited. Read the original for the full detail.